IL-10-Producing lymphocytes in inflammatory disease

International Reviews of Immunology

Volumn 32, Issue 3, 2013, Pages 324-336

  Yao, Yang ^a   Simard, Alain R ^b   Shi, Fu Dong ^a   Hao, Junwei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITÉ DE MONCTON   (Canada)

Author keywords

IL 10; Immune inflammatory disease; Lymphocytes; Regulatory cell

Indexed keywords

APRIL PROTEIN; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; LYMPHOTOXIN; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATE BUFFERED SALINE; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; ARTICLE; ARTIFICIAL MILK; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CONTACT ALLERGY; CROHN DISEASE; DISEASE COURSE; DISEASE SEVERITY; ENTEROCOLITIS; HUMAN; HYPOTHERMIA; HYPOXIA; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE INJURY; INTESTINE VILLUS; LYMPHOCYTOPOIESIS; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NECROTIZING ENTEROCOLITIS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; STEADY STATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH17 CELL; ULCERATIVE COLITIS; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES, REGULATORY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-10; KILLER CELLS, NATURAL; T-LYMPHOCYTES, REGULATORY;

EID: 84879077260     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2012.762361     Document Type: Article

References (83)

1. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV.Th2 clones secrete a factor that inhibits cytokine production byTh1 clones. J ExpMed 1989;170(6):2081-2095.
2. Moore KW, Vieira P, Fiorentino DF, et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990;248(4960):1230-1234.
3. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005;5(4):271-283.
4. O'Garra A, Barrat FJ, Castro AG, et al. Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 2008;223:114-131.
5. Moore KW, deWaalMalefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
6. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10(8):801-805.
7. Roncarolo MG, Gregori S, BattagliaM, et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006;212:28-250.
8. O'Garra A, Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007;7(6):425-428.
9. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 2007;204(2):239-243.
10. Maynard CL,Weaver CT. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev 2008;226:219-233.
11. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2(9):816-822.
12. Ryan JJ, Kashyap M, Bailey D, et al.Mast cell homeostasis: a fundamental aspect of allergic disease. Crit Rev Immunol 2007;27(1):15-32.
13. Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol 2008;8(5):391-397.
14. Williams LM, Ricchetti G, Sarma U, et al. Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology 2004;113(3):281-292.
15. Emami CN, Chokshi N,Wang J, et al. Role of interleukin-10 in the pathogenesis of necrotizing enterocolitis. AmJ Surg 2012;203(4):428-435.
16. Fedorak RN,Gangl A, ElsonCO, et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The interleukin 10 inflammatory bowel disease cooperative study group. Gastroenterology 2000;119(6):1473-1482.
17. Docke WD, Asadullah K, Belbe G, et al. Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persistingimmune effects of interleukin-10 application in psoriasis. J Leukoc Biol 2009;85(3):582-593.
18. Lopez MN, Pesce B, Kurte M, et al. A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-beta+ tolerogenic dendritic cells. Immunobiology 2011;216(10):1117-1126.
19. Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008;28(4):468-476.
20. Jankovic D, Kullberg MC, Feng CG, et al. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 2007;204(2):273-283.
21. Anderson CF, Oukka M, Kuchroo VJ, Sacks D. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 2007;204(2):285-297.
22. Gabrysova L, Nicolson KS, Streeter HB, et al. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med 2009;206(8):1755-1767.
23. Saraiva M, Christensen JR, Veldhoen M, et al. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009;31(2):209-219.
24. Gerosa F, Nisii C, Righetti S, et al. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin Immunol 1999;92(3):224-234.
25. Meyaard L, Hovenkamp E, Otto SA, Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 1996;156(8):2776-2782.
26. YsselH, DeWaalMalefyt R, RoncaroloMG, et al. IL-10 is produced by subsets of human CD4+T cell clones and peripheral blood T cells. J Immunol 1992;149(7):2378-2384.
27. Del Prete G, De CarliM, Almerigogna F, et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150(2):353-360.
28. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007;8(12): 1390-1397.
29. Fitzgerald DC, Zhang GX, El-Behi M, et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 2007;8(12):1372-1379.
30. Stumhofer JS, Silver JS, Laurence A, et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007;8(12):1363-1371.
31. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010;10(3):170-181.
32. Belkaid Y, Tarbell K. Regulatory T cells in the control of host-microorganism interactions (?). Annu Rev Immunol 2009;27:551-589.
33. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007;7(11):875-888.
34. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009;30(5):616-625.
35. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009;30(5):636-645.
36. Maynard CL, Harrington LE, Janowski KM, et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol 2007;8(9):931-941.
37. Morrissey PJ, Charrier K, Braddy S, et al. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J ExpMed 1993;178(1):237-244.
38. Powrie F, LeachMW,Mauze S, et al. Phenotypically distinct subsets ofCD4+T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5(11):1461-1471.
39. Denning TL, Kim G, Kronenberg M. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J Immunol 2005;174(12):7487-7491.
40. Guichelaar T, ten Brink CB, van Kooten PJ, et al. Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response. J Immunol 2008;180(3):1373-1381.
41. Zhang L, Yuan S, Cheng G, Guo B. Type I IFN promotes IL-10 production from T cells to suppress Th17 cells andTh17-associated autoimmune inflammation. PLoS One 2011;6(12):e28432.
42. Zhao J, Fett C, Trandem K, et al. IFN-gamma-and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J Exp Med 2011;208(8): 1571-1577.
43. Huss DJ, Winger RC, Cox GM, et al. TGF-beta signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur J Immunol 2011;41(10):2987-2996.
44. LiuY, ZhuT,CaiG, et al.ElevatedcirculatingCD4+ICOS+Foxp3+T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus. Lupus 2011;20(6):620-627.
45. Trandem K, Zhao J, Fleming E, Perlman S. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J Immunol 2011;186(6):3642-3652.
46. Chaudhry A, Samstein RM, Treuting P, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011;34(4):566-578.
47. DiLillo DJ,Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci 2010;1183:38-57.
48. Lampropoulou V, Calderon-Gomez E, Roch T, et al. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of toll-like receptors in immunity. Immunol Rev 2010;233(1):146-161.
49. Mauri C, Blair PA. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 2010;6(11):636-643.
50. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012;30:221-241.
51. Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002;3(10):944-950.
52. Lampropoulou V, Hoehlig K, Roch T, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008;180(7):4763-4773.
53. Rieger A, Bar-Or A. B-cell-derived interleukin-10 in autoimmune disease: regulating the regulators. Nat Rev Immunol 2008;8(6):486-487.
54. Knippenberg S, Peelen E, Smolders J, et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission. J Neuroimmunol 2011;239(1-2):80-86.
55. Carter NA, Rosser EC, Mauri C. IL-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of Tr1 cells and reduction of collagen-induced arthritis. Arthritis ResTher 2012;14(1):R32.
56. Fernandez L, Salinas GF, Rocha C, et al. The TNF-ligand APRIL can control CIA by regulating antibody-production and stimulating anti-inflammatory IL-10 producing B cells. Ann Rheum Dis 2011;70:A58.
57. Yanaba K, Yoshizaki A, Asano Y, et al. IL-10-producing regulatory B10 cells inhibit intestinal injury in amouse model. Am J Pathol 2011;178(2):735-743.
58. Xiao Z,Mohamood AS,Uddin S, et al. Inhibition of Fas ligand inNODmiceunmasks a protective role for IL-10 against insulitis development. Am J Pathol 2011;179(2):725-732.
59. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
60. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev 2006;214:56-72.
61. Moretta L, Ferlazzo G, Bottino C, et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006;214:219-228.
62. Perona-Wright G,Mohrs K, Szaba FM, et al. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell HostMicrobe 2009;6(6):503-512.
63. Peritt D, Robertson S, Gri G, et al. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998;161(11):5821-5824.
64. Deniz G, Erten G, Kucuksezer UC, et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 2008;180(2):850-857.
65. Moore KW, O'Garra A, deWaalMalefyt R, et al. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
66. Qian C, An H, Yu Y, et al. TLR agonists induce regulatory dendritic cells to recruitTh1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood 2007;109(8):3308-3315.
67. Mocellin S, Panelli M, Wang E, et al. IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes Immun 2004;5(8):621-630.
68. Cai G, Kastelein RA,Hunter CA. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol 1999;29(9):2658-2665.
69. Carson WE, Lindemann MJ, Baiocchi R, et al. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 1995;85(12):3577-3585.
70. Shibata Y, Foster LA, Kurimoto M, et al. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J Immunol 1998;161(8):4283-4288.
71. Chiu BC, Stolberg VR, Chensue SW. Mononuclear phagocyte-derived IL-10 suppresses the innate IL-12/IFN-gamma axis in lung-challenged aged mice. J Immunol 2008;181(5):3156-3166.
72. Scott MJ, Hoth JJ, Turina M, Woods DR, et al. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection. Cytokine 2006;33(2):79-86.
73. Coudert JD, Zimmer J, Tomasello E, et al. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 2005;106(5):1711-1717.
74. OppenheimDE, Roberts SJ, Clarke SL, et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005;6(9):928-937.
75. Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. NatMed 2009;15(3):277-284.
76. Peppa D,Micco L, Javaid A, et al. Blockade of immunosuppressive cytokines restoresNKcell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 2010;6(12):e1001227.
77. Cheong JY, Cho SW, Hwang IL, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J GastroenterolHepatol 2006;21(7):1163-1169.
78. Miyazoe S, Hamasaki K, Nakata K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002;97(8):2086-2092.
79. Stacey MA, Marsden M, Wang EC, et al. IL-10 restricts activation-induced death of NK cells during acutemurine cytomegalovirus infection. J Immunol 2011;187(6):2944-2952.
80. Grant LR, Yao ZJ, Hedrich CM, et al. Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells. Genes Immun 2008;9(4):316-327.
81. Gray M,Miles K, Salter D, et al. Apoptotic cells protectmice fromautoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA 2007;104(35):14080-14085.
82. Carter NA, Vasconcellos R, Rosser EC, et al.Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 2011;186(10):5569-5579.
83. Hao J, Liu R, Piao W, et al. Central nervous system (CNS)-resident natural killer cells suppressTh17 responses and CNS autoimmune pathology. J ExpMed 2010;207(9):1907-1921.